Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At LeastSeeking Alpha • 10/21/26
ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins UpZacks Investment Research • 10/21/26
Abbott (ABT) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 10/21/26
Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded companyPRNewsWire • 10/21/26
Big tech is wobbling. Goldman Sachs says it's time to buy these 23 unloved stocks instead.Market Watch • 10/19/26
Countdown to Abbott (ABT) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 10/16/26
3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades24/7 Wall Street • 10/15/26
The Market Is Flashing Warning Signals Not Seen in Years. Here's Why I Just Bought 3 of SCHD's Dividend Kings.The Motley Fool • 10/13/26
Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?Zacks Investment Research • 10/13/26
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 10/12/26